nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—CYP3A5—Teniposide—lymphatic system cancer	0.142	0.175	CbGbCtD
Phenelzine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.128	0.157	CbGbCtD
Phenelzine—CYP2C19—Teniposide—lymphatic system cancer	0.115	0.141	CbGbCtD
Phenelzine—CYP3A7—Vincristine—lymphatic system cancer	0.0914	0.112	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0914	0.112	CbGbCtD
Phenelzine—CYP3A5—Vincristine—lymphatic system cancer	0.0685	0.0842	CbGbCtD
Phenelzine—CYP3A4—Cytarabine—lymphatic system cancer	0.0564	0.0692	CbGbCtD
Phenelzine—CYP3A4—Teniposide—lymphatic system cancer	0.0555	0.0682	CbGbCtD
Phenelzine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0388	0.0477	CbGbCtD
Phenelzine—CYP3A4—Vincristine—lymphatic system cancer	0.0267	0.0328	CbGbCtD
Phenelzine—Metabolic acidosis—Teniposide—lymphatic system cancer	0.0112	0.0603	CcSEcCtD
Phenelzine—Metabolic acidosis—Fludarabine—lymphatic system cancer	0.00983	0.053	CcSEcCtD
Phenelzine—Digestion impaired—Fludarabine—lymphatic system cancer	0.00582	0.0313	CcSEcCtD
Phenelzine—Coma—Fludarabine—lymphatic system cancer	0.00355	0.0191	CcSEcCtD
Phenelzine—Nystagmus—Vincristine—lymphatic system cancer	0.00332	0.0179	CcSEcCtD
Phenelzine—Jaundice—Mechlorethamine—lymphatic system cancer	0.00327	0.0176	CcSEcCtD
Phenelzine—Sleep disorder—Fludarabine—lymphatic system cancer	0.00326	0.0176	CcSEcCtD
Phenelzine—Sweating—Teniposide—lymphatic system cancer	0.00237	0.0128	CcSEcCtD
Phenelzine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00235	0.0126	CcSEcCtD
Phenelzine—Coma—Carmustine—lymphatic system cancer	0.00227	0.0122	CcSEcCtD
Phenelzine—Coma—Vincristine—lymphatic system cancer	0.00217	0.0117	CcSEcCtD
Phenelzine—Agitation—Teniposide—lymphatic system cancer	0.00178	0.00957	CcSEcCtD
Phenelzine—Leukopenia—Teniposide—lymphatic system cancer	0.00173	0.00932	CcSEcCtD
Phenelzine—Ataxia—Carmustine—lymphatic system cancer	0.0017	0.00914	CcSEcCtD
Phenelzine—Urinary retention—Vincristine—lymphatic system cancer	0.00164	0.00883	CcSEcCtD
Phenelzine—Ataxia—Vincristine—lymphatic system cancer	0.00162	0.00873	CcSEcCtD
Phenelzine—Oedema—Teniposide—lymphatic system cancer	0.00158	0.0085	CcSEcCtD
Phenelzine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00158	0.00849	CcSEcCtD
Phenelzine—Agitation—Fludarabine—lymphatic system cancer	0.00156	0.00841	CcSEcCtD
Phenelzine—Tachycardia—Teniposide—lymphatic system cancer	0.00154	0.00829	CcSEcCtD
Phenelzine—Malaise—Fludarabine—lymphatic system cancer	0.00153	0.00825	CcSEcCtD
Phenelzine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00153	0.00821	CcSEcCtD
Phenelzine—Leukopenia—Fludarabine—lymphatic system cancer	0.00152	0.00819	CcSEcCtD
Phenelzine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00151	0.00815	CcSEcCtD
Phenelzine—Convulsion—Fludarabine—lymphatic system cancer	0.00147	0.00793	CcSEcCtD
Phenelzine—Discomfort—Fludarabine—lymphatic system cancer	0.00143	0.0077	CcSEcCtD
Phenelzine—Oedema—Fludarabine—lymphatic system cancer	0.00139	0.00747	CcSEcCtD
Phenelzine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00137	0.00739	CcSEcCtD
Phenelzine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00136	0.00733	CcSEcCtD
Phenelzine—Rash—Mechlorethamine—lymphatic system cancer	0.00135	0.00727	CcSEcCtD
Phenelzine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00135	0.00726	CcSEcCtD
Phenelzine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00134	0.00722	CcSEcCtD
Phenelzine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00134	0.0072	CcSEcCtD
Phenelzine—Weight increased—Mitoxantrone—lymphatic system cancer	0.00132	0.00711	CcSEcCtD
Phenelzine—Feeling abnormal—Teniposide—lymphatic system cancer	0.0013	0.007	CcSEcCtD
Phenelzine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00129	0.00697	CcSEcCtD
Phenelzine—Sweating—Vincristine—lymphatic system cancer	0.00127	0.00686	CcSEcCtD
Phenelzine—Nausea—Mechlorethamine—lymphatic system cancer	0.00127	0.00685	CcSEcCtD
Phenelzine—Jaundice—Mitoxantrone—lymphatic system cancer	0.00126	0.00679	CcSEcCtD
Phenelzine—Body temperature increased—Teniposide—lymphatic system cancer	0.00125	0.00672	CcSEcCtD
Phenelzine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00125	0.00671	CcSEcCtD
Phenelzine—Sweating—Mitoxantrone—lymphatic system cancer	0.00124	0.00668	CcSEcCtD
Phenelzine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00122	0.00657	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0012	0.00645	CcSEcCtD
Phenelzine—Fatigue—Fludarabine—lymphatic system cancer	0.0012	0.00644	CcSEcCtD
Phenelzine—Constipation—Fludarabine—lymphatic system cancer	0.00119	0.00639	CcSEcCtD
Phenelzine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00116	0.00623	CcSEcCtD
Phenelzine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00114	0.00615	CcSEcCtD
Phenelzine—Asthenia—Teniposide—lymphatic system cancer	0.00113	0.0061	CcSEcCtD
Phenelzine—Malaise—Bleomycin—lymphatic system cancer	0.00112	0.00605	CcSEcCtD
Phenelzine—Pruritus—Teniposide—lymphatic system cancer	0.00112	0.00601	CcSEcCtD
Phenelzine—Leukopenia—Bleomycin—lymphatic system cancer	0.00112	0.00601	CcSEcCtD
Phenelzine—Body temperature increased—Fludarabine—lymphatic system cancer	0.0011	0.0059	CcSEcCtD
Phenelzine—Coma—Methotrexate—lymphatic system cancer	0.00105	0.00567	CcSEcCtD
Phenelzine—Discomfort—Bleomycin—lymphatic system cancer	0.00105	0.00564	CcSEcCtD
Phenelzine—Vision blurred—Carmustine—lymphatic system cancer	0.00102	0.00552	CcSEcCtD
Phenelzine—Tremor—Carmustine—lymphatic system cancer	0.00102	0.00549	CcSEcCtD
Phenelzine—Oedema—Bleomycin—lymphatic system cancer	0.00102	0.00548	CcSEcCtD
Phenelzine—Vomiting—Teniposide—lymphatic system cancer	0.001	0.0054	CcSEcCtD
Phenelzine—Agitation—Carmustine—lymphatic system cancer	0.000999	0.00538	CcSEcCtD
Phenelzine—Asthenia—Fludarabine—lymphatic system cancer	0.000995	0.00536	CcSEcCtD
Phenelzine—Rash—Teniposide—lymphatic system cancer	0.000995	0.00536	CcSEcCtD
Phenelzine—Dermatitis—Teniposide—lymphatic system cancer	0.000994	0.00535	CcSEcCtD
Phenelzine—Headache—Teniposide—lymphatic system cancer	0.000989	0.00532	CcSEcCtD
Phenelzine—Pruritus—Fludarabine—lymphatic system cancer	0.000981	0.00528	CcSEcCtD
Phenelzine—Leukopenia—Carmustine—lymphatic system cancer	0.000973	0.00524	CcSEcCtD
Phenelzine—Agitation—Vincristine—lymphatic system cancer	0.000954	0.00514	CcSEcCtD
Phenelzine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000953	0.00513	CcSEcCtD
Phenelzine—Convulsion—Carmustine—lymphatic system cancer	0.000942	0.00507	CcSEcCtD
Phenelzine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000938	0.00505	CcSEcCtD
Phenelzine—Nausea—Teniposide—lymphatic system cancer	0.000937	0.00505	CcSEcCtD
Phenelzine—Leukopenia—Vincristine—lymphatic system cancer	0.000929	0.005	CcSEcCtD
Phenelzine—Anxiety—Carmustine—lymphatic system cancer	0.000923	0.00497	CcSEcCtD
Phenelzine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000913	0.00492	CcSEcCtD
Phenelzine—Malaise—Mitoxantrone—lymphatic system cancer	0.000912	0.00491	CcSEcCtD
Phenelzine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000905	0.00487	CcSEcCtD
Phenelzine—Convulsion—Vincristine—lymphatic system cancer	0.0009	0.00484	CcSEcCtD
Phenelzine—Oedema—Carmustine—lymphatic system cancer	0.000888	0.00478	CcSEcCtD
Phenelzine—Vomiting—Fludarabine—lymphatic system cancer	0.000882	0.00475	CcSEcCtD
Phenelzine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000876	0.00472	CcSEcCtD
Phenelzine—Rash—Fludarabine—lymphatic system cancer	0.000874	0.00471	CcSEcCtD
Phenelzine—Dermatitis—Fludarabine—lymphatic system cancer	0.000874	0.0047	CcSEcCtD
Phenelzine—Headache—Fludarabine—lymphatic system cancer	0.000869	0.00468	CcSEcCtD
Phenelzine—Tachycardia—Carmustine—lymphatic system cancer	0.000866	0.00466	CcSEcCtD
Phenelzine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000858	0.00462	CcSEcCtD
Phenelzine—Discomfort—Mitoxantrone—lymphatic system cancer	0.00085	0.00458	CcSEcCtD
Phenelzine—Oedema—Vincristine—lymphatic system cancer	0.000847	0.00456	CcSEcCtD
Phenelzine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000838	0.00451	CcSEcCtD
Phenelzine—Oedema—Mitoxantrone—lymphatic system cancer	0.000825	0.00444	CcSEcCtD
Phenelzine—Nausea—Fludarabine—lymphatic system cancer	0.000824	0.00444	CcSEcCtD
Phenelzine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000819	0.00441	CcSEcCtD
Phenelzine—Shock—Mitoxantrone—lymphatic system cancer	0.000812	0.00437	CcSEcCtD
Phenelzine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000805	0.00434	CcSEcCtD
Phenelzine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000804	0.00433	CcSEcCtD
Phenelzine—Insomnia—Carmustine—lymphatic system cancer	0.000803	0.00432	CcSEcCtD
Phenelzine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000798	0.0043	CcSEcCtD
Phenelzine—Paraesthesia—Carmustine—lymphatic system cancer	0.000797	0.00429	CcSEcCtD
Phenelzine—Somnolence—Carmustine—lymphatic system cancer	0.000789	0.00425	CcSEcCtD
Phenelzine—Ataxia—Methotrexate—lymphatic system cancer	0.000787	0.00424	CcSEcCtD
Phenelzine—Insomnia—Vincristine—lymphatic system cancer	0.000766	0.00413	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000766	0.00413	CcSEcCtD
Phenelzine—Paraesthesia—Vincristine—lymphatic system cancer	0.000761	0.0041	CcSEcCtD
Phenelzine—Constipation—Carmustine—lymphatic system cancer	0.000759	0.00409	CcSEcCtD
Phenelzine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000741	0.00399	CcSEcCtD
Phenelzine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000734	0.00395	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000732	0.00394	CcSEcCtD
Phenelzine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000731	0.00394	CcSEcCtD
Phenelzine—Fatigue—Vincristine—lymphatic system cancer	0.000731	0.00393	CcSEcCtD
Phenelzine—Asthenia—Bleomycin—lymphatic system cancer	0.00073	0.00393	CcSEcCtD
Phenelzine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000726	0.00391	CcSEcCtD
Phenelzine—Constipation—Vincristine—lymphatic system cancer	0.000725	0.0039	CcSEcCtD
Phenelzine—Pruritus—Bleomycin—lymphatic system cancer	0.000719	0.00387	CcSEcCtD
Phenelzine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000711	0.00383	CcSEcCtD
Phenelzine—Constipation—Mitoxantrone—lymphatic system cancer	0.000706	0.0038	CcSEcCtD
Phenelzine—Body temperature increased—Carmustine—lymphatic system cancer	0.000702	0.00378	CcSEcCtD
Phenelzine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00068	0.00366	CcSEcCtD
Phenelzine—Body temperature increased—Vincristine—lymphatic system cancer	0.00067	0.00361	CcSEcCtD
Phenelzine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000666	0.00359	CcSEcCtD
Phenelzine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000652	0.00351	CcSEcCtD
Phenelzine—Vomiting—Bleomycin—lymphatic system cancer	0.000647	0.00348	CcSEcCtD
Phenelzine—Drowsiness—Methotrexate—lymphatic system cancer	0.000645	0.00347	CcSEcCtD
Phenelzine—Rash—Bleomycin—lymphatic system cancer	0.000641	0.00345	CcSEcCtD
Phenelzine—Dermatitis—Bleomycin—lymphatic system cancer	0.000641	0.00345	CcSEcCtD
Phenelzine—Asthenia—Carmustine—lymphatic system cancer	0.000637	0.00343	CcSEcCtD
Phenelzine—Sweating—Methotrexate—lymphatic system cancer	0.000618	0.00333	CcSEcCtD
Phenelzine—Asthenia—Vincristine—lymphatic system cancer	0.000608	0.00327	CcSEcCtD
Phenelzine—Nausea—Bleomycin—lymphatic system cancer	0.000604	0.00325	CcSEcCtD
Phenelzine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000592	0.00319	CcSEcCtD
Phenelzine—Dizziness—Carmustine—lymphatic system cancer	0.000587	0.00316	CcSEcCtD
Phenelzine—Vomiting—Carmustine—lymphatic system cancer	0.000564	0.00304	CcSEcCtD
Phenelzine—Dizziness—Vincristine—lymphatic system cancer	0.00056	0.00302	CcSEcCtD
Phenelzine—Rash—Carmustine—lymphatic system cancer	0.00056	0.00301	CcSEcCtD
Phenelzine—Dermatitis—Carmustine—lymphatic system cancer	0.000559	0.00301	CcSEcCtD
Phenelzine—Headache—Carmustine—lymphatic system cancer	0.000556	0.00299	CcSEcCtD
Phenelzine—Vomiting—Vincristine—lymphatic system cancer	0.000539	0.0029	CcSEcCtD
Phenelzine—Rash—Vincristine—lymphatic system cancer	0.000534	0.00288	CcSEcCtD
Phenelzine—Dermatitis—Vincristine—lymphatic system cancer	0.000534	0.00287	CcSEcCtD
Phenelzine—Headache—Vincristine—lymphatic system cancer	0.000531	0.00286	CcSEcCtD
Phenelzine—Nausea—Carmustine—lymphatic system cancer	0.000527	0.00284	CcSEcCtD
Phenelzine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000525	0.00283	CcSEcCtD
Phenelzine—Rash—Mitoxantrone—lymphatic system cancer	0.00052	0.0028	CcSEcCtD
Phenelzine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00052	0.0028	CcSEcCtD
Phenelzine—Headache—Mitoxantrone—lymphatic system cancer	0.000517	0.00278	CcSEcCtD
Phenelzine—Nausea—Vincristine—lymphatic system cancer	0.000503	0.00271	CcSEcCtD
Phenelzine—Nausea—Mitoxantrone—lymphatic system cancer	0.00049	0.00264	CcSEcCtD
Phenelzine—Vision blurred—Methotrexate—lymphatic system cancer	0.000475	0.00256	CcSEcCtD
Phenelzine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000467	0.00252	CcSEcCtD
Phenelzine—Malaise—Methotrexate—lymphatic system cancer	0.000454	0.00245	CcSEcCtD
Phenelzine—Leukopenia—Methotrexate—lymphatic system cancer	0.000451	0.00243	CcSEcCtD
Phenelzine—Convulsion—Methotrexate—lymphatic system cancer	0.000436	0.00235	CcSEcCtD
Phenelzine—Discomfort—Methotrexate—lymphatic system cancer	0.000424	0.00228	CcSEcCtD
Phenelzine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000397	0.00214	CcSEcCtD
Phenelzine—Insomnia—Methotrexate—lymphatic system cancer	0.000372	0.002	CcSEcCtD
Phenelzine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000369	0.00199	CcSEcCtD
Phenelzine—Somnolence—Methotrexate—lymphatic system cancer	0.000365	0.00197	CcSEcCtD
Phenelzine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000362	0.00195	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000355	0.00191	CcSEcCtD
Phenelzine—Fatigue—Methotrexate—lymphatic system cancer	0.000354	0.00191	CcSEcCtD
Phenelzine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000339	0.00182	CcSEcCtD
Phenelzine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000325	0.00175	CcSEcCtD
Phenelzine—Asthenia—Methotrexate—lymphatic system cancer	0.000295	0.00159	CcSEcCtD
Phenelzine—Pruritus—Methotrexate—lymphatic system cancer	0.000291	0.00157	CcSEcCtD
Phenelzine—Dizziness—Methotrexate—lymphatic system cancer	0.000272	0.00146	CcSEcCtD
Phenelzine—Vomiting—Methotrexate—lymphatic system cancer	0.000261	0.00141	CcSEcCtD
Phenelzine—Rash—Methotrexate—lymphatic system cancer	0.000259	0.0014	CcSEcCtD
Phenelzine—Dermatitis—Methotrexate—lymphatic system cancer	0.000259	0.00139	CcSEcCtD
Phenelzine—Headache—Methotrexate—lymphatic system cancer	0.000258	0.00139	CcSEcCtD
Phenelzine—Nausea—Methotrexate—lymphatic system cancer	0.000244	0.00132	CcSEcCtD
